ABSTRACT
At first glance, genetic testing for a late-onset disease such as Alzheimer’s Disease (AD) might not pose any new ethical questions as compared to existing genetic testing for diseases such as Huntington disease or breast cancer where their use has been widely discussed in ethical debates.
